Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03836378 · ClinicalTrials.gov registry record · NA
Addition of Dehydrated Human Amnion-Chorion Membrane During Scaling and Root Planing
A NA study of Periodontal Diseases, sponsored by University of Colorado, Denver.
- Active
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT03836378: Active NA study of Periodontal Diseases, sponsored by University of Colorado, Denver.
NCT03836378 is a NA study of Periodontal Diseases that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 250 participants, above the 145-participant average among 15 other Periodontal Diseases trials with a reported enrollment target (72% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03836378, a NA study of Periodontal Diseases, is active but no longer recruiting, sponsored by University of Colorado, Denver.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
Hypothesis: There will be an additional reduction of pocket depth and gain of clinical attachment when dehydrated human amnion-chorion membrane (dHACM) is placed into the periodontal disease defect after mechanical scaling and root planing. Specific Aim 1: to compare the clinical and radiographical outcome of using dehydrated human amnion-chorion membrane (dHACM) (commercially available as BioXclude®) with mechanical scaling and root planing.
Primary Outcome
Mean change in probing depths (using a UNC probe to measure probing depths).
Conditions Studied
Interventions
- PROCEDURE BioXclude™
Study Locations (1)
Colorado
- Sangeetha Chandrasekaran - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2020-11-01 |
| Est. Completion | 2027-11-01 |
| Phase | NA |
What the registry record for NCT03836378 still lists
NCT03836378 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 145-participant average among 15 other Periodontal Diseases trials with a reported enrollment target (72% higher).
The record links to 1 condition, with Periodontal Diseases appearing as the primary indexed condition, and to 1 intervention - of which BioXclude™ is the first listed.
NCT03836378 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT03836378 about?
NCT03836378 is a clinical study titled "Addition of Dehydrated Human Amnion-Chorion Membrane During Scaling and Root Planing". Hypothesis: There will be an additional reduction of pocket depth and gain of clinical attachment when dehydrated human amnion-chorion membrane (dHACM) is placed into the periodontal disease defect after mechanical scaling and root planing. Specific Aim 1: to compare the clinical and radiographical...
What is the current status of trial NCT03836378?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2020-11-01. Estimated completion is 2027-11-01.
What conditions does trial NCT03836378 study?
This clinical trial studies the following conditions: Periodontal Diseases.
What interventions are being tested in trial NCT03836378?
The interventions under investigation include: BioXclude™ (PROCEDURE).
Who is sponsoring clinical trial NCT03836378?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03836378 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Periodontal Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03836378's enrollment target sits among peer trials
250 3rd of 15 higher than 13 of 15 other Periodontal Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Periodontal Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Novel Dental Gel as an Adjunct to Scaling and Root Planing
RECRUITING · NA
-
Oral Health Intervention in Adult Primary Care
RECRUITING · NA
-
An Evaluation of the Effect of the Erchonia FX-405 Laser as an Adjunctive Treatment of Periodontitis
RECRUITING · NA
-
F.L.O.S.S. Project (Facilitated Lessons on Oral and Systemic Health in Survivors)
RECRUITING · NA
-
Microsurgery and Periodontal Healing
RECRUITING · NA
-
Application of L-PRF in Periodontal Surgery
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI